United States Magnetoencephalography Market Size, Share, and COVID-19 Impact Analysis, By Application (Clinical and Research), By End Use (Hospitals, Imaging Centers, and Academic & research institutes), and United States Magnetoencephalography Market Insights, Industry Trend, Forecasts to 2035

United States Magnetoencephalography Market Insights Forecasts to 2035

• The US Magnetoencephalography Market Size Was Estimated at USD 76.6 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.83% from 2025 to 2035
• The US Magnetoencephalography Market Size is Expected to Reach USD 142.9 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The United States Magnetoencephalography Market Size is anticipated to Reach USD 142.9 Million by 2035, Growing at a CAGR of 5.83% from 2025 to 2035. The expansion of the United States magnetoencephalography market is propelled by the growing prevalence of neurological diseases that cause death and disability, along with the increasing technological advancements in magnetoencephalography (MEG) systems and their increasing usage.

Market Overview

Magnetoencephalography is a non-invasive neuroimaging method that monitors the small magnetic fields produced by electrical currents passing through brain neurons. MEG scanner is one of the leading imaging methods available to look at epilepsy, brain tumours, emotion, pain perception, etc., fundamentally, all diseases or conditions of the nervous system. It relies on neuromagnetic impulses that pass through the scalp and skull without being altered. Despite existing for decades, this technologys potential is now becoming apparent due to advancements in hardware and processing power. Neuroimaging is in a complete paradigm shift now, being driven by the move to mobile and compact MEG. Compact MEG is not a fanciful notion anymore due to advancements in magnets and sensor technology, and improved shielding has made compact MEG a realistic future option. These devices have outstanding sensitivity, accuracy, and flexibility in clinical and research settings. These devices will increasingly make MEG scanners available and expand MEGs reach into places like small clinics and small research labs. Portable MEG will continue to grow the magnetoencephalography market by increasing access and lowering costs, which will help research build capacity and enable incorporation into standard clinical practice, advancing neurology and neuroscience.

In the United States, MEG development and adoption are being rapidly advanced by federal agencies and public-private partnerships through targeted finance and infrastructure investment. The Qualcomm Institute at UC San Diego received $2 million from the NIH in 2023 for a new MEG system that will enhance clinical research on PTSD, Alzheimers disease, autism, schizophrenia, concussions, brain tumours, and epilepsy.

Report Coverage

This research report categorizes the market for the United States magnetoencephalography market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States magnetoencephalography market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States magnetoencephalography market.

Driving Factors

The growth of the United States magnetoencephalography market is boosted by the combination of its use with other imaging modalities, such as MRI and PET, which vastly improves diagnostic capabilities as well as market growth. Combining the fast temporal resolution of MEG with the spatially detailed structural imaging of MRI and the functional imaging of PET allows an understanding of brain function and pathology that cannot be acquired through functional imaging alone. The ability to better localise brain activity, diagnose neurological disorders, and evaluate treatment effects in clinical and research contexts is driving increased use due to the synergistic effect of the modalities. This integration is fuelling the growth of the magnetoencephalography market by enhancing efficacy and accessibility for pioneers in the field.

Restraining Factors

The United States magnetoencephalography market faces obstacles like the accessibility is limited to well-funded universities because of extremely large capital and operating expenses, including expensive shielded rooms, cryogenic upkeep, and millions in equipment. The technical complexities of use and the lack of trained personnel present additional substantial barriers.

Market Segmentation

The United States magnetoencephalography market share is classified into application and end use.

• The clinical segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States magnetoencephalography market is segmented by application into clinical and research. Among these, the clinical segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The segment is driven because neurodegenerative diseases are prevalent. In clinical settings, MEG has accurate diagnostic abilities with exceptional temporal and spatial resolution, often far superior. It is also useful in diagnosis for several forms of neurological disease, and for locating functioning regions of the brain, i.e., speech, and movement, in addition to pre-operative mapping of epileptic zones.

• The hospitals segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the end use, the United States magnetoencephalography market is segmented into hospitals, imaging centers, and academic & research institutes. Among these, the hospitals segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is propelled by its easy MEG technological systems that are in hospitals for a range of diagnostic applications, the growth in neurological disorders necessitating MEGs advanced imaging quality, the availability of hospital funding, and supporting infrastructure to offset the high costs of MEG technology.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States magnetoencephalography market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• FieldLine
• Ricoh USA Inc.
• MEGIN
• Compumedics
• Advanced Brain Monitoring, Inc.
• Cadwell Laboratories, Inc.
• Electrical Geodesics, Inc.
• HeadSense Medical, Inc.
• Rimed, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States magnetoencephalography market based on the following segments:

United States Magnetoencephalography Market, By Application

• Clinical
• Research

United States Magnetoencephalography Market, By End Use

• Hospitals
• Imaging Centers
• Academic & research institutes